The rulebook decides where health AI can scale
Abu Dhabi: rules first, scale second
You can't support an Abu Dhabi hospital's AI from Stockholm.
That's not my opinion. It's in the rulebook.
Abu Dhabi's Responsible AI Standard says compute and storage must sit inside the UAE, and support teams are expected to work from there too. It applies to every licensed healthcare provider in the emirate, including the AI they buy from outside vendors.
The rest of it asks what any clinician would ask.
Who's in charge? A human, always.
What happens when it fails? Care carries on.
Does it work on our patients? Prove it before you deploy.
Does it fit how we already work? It has to.
As a doctor who still sees patients, I'd ask the same before letting any tool into my clinic.
Clinicians don't ask how clever the model is. We ask whether it slows the clinic down.
And this regulator moves. The standard took effect in October 2025. Seven months later it announced a network connecting roughly 100 operating theatres, across four hospital groups that compete for the same patients. One platform, under its rules.
Rules first. Scale second.
European medtech has an edge here, the Nordics most of all. Registries and real-world evidence are a habit there, and these rules reward the habit.
But evidence gets you through the door. A team on the ground keeps you in the room.
The standard is due for review this month. The Abu Dhabi Future Health Summit, convened by the same regulator, opens on 20 October.
Europe: governance moves into deployment
Digital health governance is shifting from concept to deployment, and the implications for cross border healthcare systems are significant.
At the EPH Conference, HaDEA made clear that AI-enabled diagnostics and population health tools will only scale if they are built on interoperable data systems, robust governance frameworks, and clinical validation that extends beyond controlled pilots.
This isn’t just a European conversation. As healthcare systems from the Nordics to the Gulf implement digital transformation strategies aligned with national priorities like Vision 2030, the challenge is consistent: how do you deploy AI tools that clinicians trust, regulators approve, and patients benefit from across different regulatory environments?
The answer lies in co-designing solutions with three non-negotiables:
Data quality and interoperability: Systems must communicate across borders and care settings without creating new silos.
Transparent governance: Explainability, equity, and accountability cannot be afterthoughts, especially in early detection where diagnostic accuracy directly impacts outcomes.
Real-world validation: Performance in controlled trials must translate to operational settings where workload, clinical workflows, and diverse patient populations are variables, not constants.
Through deploying AI diagnostics in NHS settings and advising on Nordic-Gulf healthcare partnerships, I’ve seen that successful digital transformation requires equal parts clinical evidence, regulatory alignment, and stakeholder trust, particularly when scaling solutions across jurisdictions with different healthcare architectures.
For clinical leaders, investors, and innovators working at this intersection: the opportunity is to engage early with standards, involve frontline clinicians in design, and build deployment strategies that account for real world complexity from day one.
The systems that succeed will be those designed not just to work, but to be trusted.
Reference:
A global rulebook in the making
The World Health Organization (WHO), ITU, and WIPO have established the Global Initiative on AI for Health (GI-AI4H). The aim is to create a single, international rulebook to guarantee AI in healthcare is safe, ethical, and effective for everyone, with a focus on equitable access for developing nations.
This move could transform digital health. A unified framework can replace today’s fragmented rules, giving clinicians and patients confidence that AI tools meet shared benchmarks for safety and ethics. It also opens new space for collaboration connecting innovators, regulators, and health systems to share real world data and scale proven technologies responsibly.
This is vital for building trust with clinicians and patients.
As a GP and Clinical Advisor, watching medicine merge with technology, I know success hinges on innovation that is truly clinically grounded. My focus is driving ethical, evidence based adoption.
This means applying cross cultural fluency and strategic thinking to localize these global standards so they work effectively on the ground.
A framework is just ink on paper until people put it into practice. We must always ensure AI enhances human judgement and remains anchored in fairness and equitable care for all.
What it means
For a company planning Gulf entry, the practical lesson is to read the local standard before the sales plan. Where the data must sit, who supports the system and what evidence the regulator expects will shape the cost and the timeline more than the technology itself.